GRAIL Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
1,170
- Stock Symbol
-
GRAL
- Investments
-
3
- Share Price
-
$28.01
- (As of Wednesday Closing)
GRAIL General Information
Description
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Contact Information
Website
www.grail.comCorporate Office
- 1525 O'Brien Drive
- Menlo Park, CA 94025
- United States
Corporate Office
- 1525 O'Brien Drive
- Menlo Park, CA 94025
- United States
GRAIL Stock Performance
As of 19-Mar-2025, GRAIL’s stock price is $28.01. Its current market cap is $949M with 33.9M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $28.01 | $28.18 | $12.33 - $63.99 | $949M | 33.9M | 1.46M | -$63.54 |
GRAIL Financials Summary
As of 31-Dec-2024, GRAIL has a trailing 12-month revenue of $126M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | (181,586) | (181,586) | ||
| Revenue | 125,595 | 125,595 | 93,105 | 55,550 |
| EBITDA | (2,031,038) | (2,031,038) | (1,356,893) | (5,288,365) |
| Net Income | (2,027,005) | (2,027,005) | (1,465,685) | (5,399,098) |
| Total Assets | 2,983,307 | 2,983,307 | 3,913,814 | 4,937,986 |
| Total Debt | 68,141 | 68,141 | 84,407 | 96,010 |
GRAIL Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GRAIL Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
GRAIL Comparisons
Industry
Financing
Details
GRAIL Competitors (31)
One of GRAIL’s 31 competitors is NuProbe, a Venture Capital-Backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NuProbe | Venture Capital-Backed | Houston, TX | ||||
| Advanced Cell Diagnostics | Formerly VC-backed | Minneapolis, MN | ||||
| Recombinetics | Venture Capital-Backed | Eagan, MN | ||||
| CellMax Life | Venture Capital-Backed | Sunnyvale, CA | ||||
| CellMade Laboratories | Corporation | Ruffieux, France |
GRAIL Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
GRAIL Patents
GRAIL Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250037876-A1 | Systems and methods for developing and utilizing a hematologic prognostic classifier | Pending | 27-Jul-2023 | ||
| US-20240412821-A1 | Methylation-based biological sex prediction | Pending | 09-Jun-2023 | ||
| US-20240360504-A1 | Cancer classification with cancer signal of origin thresholding | Pending | 28-Apr-2023 | ||
| US-20240312564-A1 | White blood cell contamination detection | Pending | 13-Mar-2023 | ||
| US-20240309461-A1 | Sample barcode in multiplex sample sequencing | Pending | 13-Mar-2023 | C12Q1/6886 |
GRAIL Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GRAIL Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GRAIL Investments & Acquisitions (3)
GRAIL’s most recent deal was a Seed Round with Youmio for . The deal was made on 05-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Youmio | 05-Apr-2024 | Seed Round | Entertainment Software | ||
| MetalCore | 12-Mar-2024 | Early Stage VC | Entertainment Software | ||
| Cirina | 31-May-2017 | Merger/Acquisition | Biotechnology |
GRAIL ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
GRAIL FAQs
-
When was GRAIL founded?
GRAIL was founded in 2015.
-
Where is GRAIL headquartered?
GRAIL is headquartered in Menlo Park, CA.
-
What is the size of GRAIL?
GRAIL has 1,170 total employees.
-
What industry is GRAIL in?
GRAIL’s primary industry is Biotechnology.
-
Is GRAIL a private or public company?
GRAIL is a Public company.
-
What is GRAIL’s stock symbol?
The ticker symbol for GRAIL is GRAL.
-
What is the current stock price of GRAIL?
As of 19-Mar-2025 the stock price of GRAIL is $28.01.
-
What is the current market cap of GRAIL?
The current market capitalization of GRAIL is $949M.
-
What is GRAIL’s current revenue?
The trailing twelve month revenue for GRAIL is $126M.
-
Who are GRAIL’s competitors?
NuProbe, Advanced Cell Diagnostics, Recombinetics, CellMax Life, and CellMade Laboratories are some of the 31 competitors of GRAIL.
-
What is GRAIL’s annual earnings per share (EPS)?
GRAIL’s EPS for 12 months was -$63.54.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
